中华实验和临床病毒学杂志
中華實驗和臨床病毒學雜誌
중화실험화림상병독학잡지
CHINESE JOURNAL OF EXPERIMENTAL AND CLINICAL VIROLOGY
2010年
6期
424-426
,共3页
张丽%颜丙玉%纪峰%李漫时%宋立志%徐爱强
張麗%顏丙玉%紀峰%李漫時%宋立誌%徐愛彊
장려%안병옥%기봉%리만시%송립지%서애강
肝炎病毒,乙型%抗原%突变
肝炎病毒,乙型%抗原%突變
간염병독,을형%항원%돌변
Hepatitis B virus%Antigens%Mutation
目的 了解目前山东省社区人群乙型肝炎病毒(HBV)"a"抗原决定簇突变率和突变形式,探讨乙肝疫苗(HepB)接种对"a"抗原决定簇突变的影响.方法 在全省1~59岁社区人群中通过多阶段随机抽样确定调查对象,通过询问(15岁以上)或查阅接种记录(14岁以下)了解调查对象HepB免疫史;采集血标本,酶联免疫吸附方法 检测血清乙肝表面抗原(HBsAg),阳性者提取血清DNA,采用巢式PCR方法 扩增HBV S基因,测序后与标准序列进行比较.结果 共对7601人进行调查和血标本采集,得到HBsAg阳性标本239份(3.14%),可用于HBV DNA提取206份,扩增HBV S基因并成功测序102份.15份血清标本检测到13种HBV"a"抗原决定簇突变,突变率为14.70%(15/102).新生儿普种HepB前、后出生调查对象间,以及有、无HepB免疫史调查对象间"a"抗原决定簇突变率差异均无统计学意义.结论 目前山东社区人群中"a"抗原决定簇突变率较低且突变位点比较分散;未发现HepB接种对人群"a"抗原决定簇突变产生影响.
目的 瞭解目前山東省社區人群乙型肝炎病毒(HBV)"a"抗原決定簇突變率和突變形式,探討乙肝疫苗(HepB)接種對"a"抗原決定簇突變的影響.方法 在全省1~59歲社區人群中通過多階段隨機抽樣確定調查對象,通過詢問(15歲以上)或查閱接種記錄(14歲以下)瞭解調查對象HepB免疫史;採集血標本,酶聯免疫吸附方法 檢測血清乙肝錶麵抗原(HBsAg),暘性者提取血清DNA,採用巢式PCR方法 擴增HBV S基因,測序後與標準序列進行比較.結果 共對7601人進行調查和血標本採集,得到HBsAg暘性標本239份(3.14%),可用于HBV DNA提取206份,擴增HBV S基因併成功測序102份.15份血清標本檢測到13種HBV"a"抗原決定簇突變,突變率為14.70%(15/102).新生兒普種HepB前、後齣生調查對象間,以及有、無HepB免疫史調查對象間"a"抗原決定簇突變率差異均無統計學意義.結論 目前山東社區人群中"a"抗原決定簇突變率較低且突變位點比較分散;未髮現HepB接種對人群"a"抗原決定簇突變產生影響.
목적 료해목전산동성사구인군을형간염병독(HBV)"a"항원결정족돌변솔화돌변형식,탐토을간역묘(HepB)접충대"a"항원결정족돌변적영향.방법 재전성1~59세사구인군중통과다계단수궤추양학정조사대상,통과순문(15세이상)혹사열접충기록(14세이하)료해조사대상HepB면역사;채집혈표본,매련면역흡부방법 검측혈청을간표면항원(HBsAg),양성자제취혈청DNA,채용소식PCR방법 확증HBV S기인,측서후여표준서렬진행비교.결과 공대7601인진행조사화혈표본채집,득도HBsAg양성표본239빈(3.14%),가용우HBV DNA제취206빈,확증HBV S기인병성공측서102빈.15빈혈청표본검측도13충HBV"a"항원결정족돌변,돌변솔위14.70%(15/102).신생인보충HepB전、후출생조사대상간,이급유、무HepB면역사조사대상간"a"항원결정족돌변솔차이균무통계학의의.결론 목전산동사구인군중"a"항원결정족돌변솔교저차돌변위점비교분산;미발현HepB접충대인군"a"항원결정족돌변산생영향.
Objective To determine the rate and type of "a" dominant mutation of hepatitis B virus (HBV) in community-based population of Shandong province and the possible effect of hepatitis B vaccination upon "a" dominant mutation. Methods The anticipants aged 1-59 years were selected by multi-stage random sampling from the general population of Shandong province. Hepatitis B vaccination status was obtained by inquisition (for those over 15 years old) or immunization record (for those under 14 years old). The blood samples were collected and detected for HBsAg by ELISA. HBV DNA was extracted from the sera with positive HBsAg and S gene was amplified by nested-PCR. The PCR produce was sequenced and compared with the standard sequence. Results Overall, 7601 anticipants were investigated.HBV DNA was successfully amplified and sequenced in 102 of 239 samples with positive HBsAg. 14. 70% sera samples mutated in HBV "a" determinant region and 13 mutation types were detected. There were no statistically differences in the mutation rate by age groups ( born before or after national universal infant hepatitis B vaccination) and hepatitis B vaccination status. Conclusion The "a" determinant mutation seemed to be uncommon in community-based population of Shandong province and the mutation sites were relatively scattered. Hepatitis B vaccination has no effect on "a" dominant mutation of hepatitis B virus.